Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$49.20
0.671.38%
Last update: Oct 6, 4:31 AM
$49.20
0.671.38%
AnaptysBio Inc (ANAB) Stock Price, Quote, News & History
ANABNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of AnaptysBio (NASDAQ:ANAB) through any online brokerage.
Other companies in AnaptysBio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
AnaptysBio has a consensus price target of $69.81.
The stock price for AnaptysBio (NASDAQ: ANAB) is $49.2 last updated October 6, 2026 at 4:31 AM EDT.
There are no upcoming dividends for AnaptysBio.
AnaptysBio does not have any upcoming earnings scheduled.
There is no upcoming split for AnaptysBio.
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
